CAPR → $3.12 by Oct 7, 2028.

|Rank|Ticker|Approx. Price|Approx. Loss|What is driving it?| |:-|:-|:-|:-|:-| |1|**CAPR**|**About $3.10–$3.15**|**−53%**|A major negative reaction following company/FDA-related developments and heavy selling pressure.| |:-|:-|:-|:-|:-| |2|**INO**|**$0.59–$0.61**|**−41% to −43%**|Investors are reacting negatively to company developments, creating a high-volume biotech sell-off.| |:-|:-|:-|:-|:-| |3|**YAAS**|**$2.00–$2.20**|**−25% to −32%**|Strong selling pressure and momentum liquidation are pushing the low-priced stock lower.| |:-|:-|:-|:-|:-| |4|**YYAI**|**About $0.18**|**About −38%**|The stock is under severe penny-stock selling pressure and has moved toward new lows.| |:-|:-|:-|:-|:-| |5|**CODX**|**Around $1.44–$1.51**|**Weak/volatile**|The stock has been pressured despite recent diagnostic-test developments; biotech traders remain …